Hisamitsu Pharmaceutical Co. Inc sales and marketing update

Hisamitsu’s Noven Pharmaceuticals Inc. subsidiary launched 0.025 mg/day Minivelle estradiol transdermal system in the U.S. to prevent postmenopausal osteoporosis. Minivelle now comes in 0.025, 0.037...